Covishield Risks Ignite Legal Challenges
For the first time, pharmaceutical giant AstraZeneca has admitted that its COVID-19 vaccine may cause a rare health condition, legally known as Covishield and Vaxzevria worldwide. The Telegraph reported that this immunization could sometimes result in thrombosis with thrombocytopenia syndrome (TTS), a disease-causing blood clots and low platelets, according to the manufacturer in court documents. … Read more